Insider · CIK 0002022087

Bredt David

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0002022087

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-19	RAPPRapport Therapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,000 sh	—	—	88,080
2026-02-19	RAPPRapport Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,000 sh	$1.80	+$10.8K	393,075
2026-02-17	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,200 sh	$29.59	−$65.1K	387,075
2026-02-17	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,400 sh	$28.95	−$156K	389,275
2026-02-17	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−900 sh	$28.02	−$25.2K	394,675
2026-02-02	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+103K sh	—	—	103,000
2026-01-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−200 sh	$27.40	−$5,480	395,575
2026-01-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,300 sh	$26.83	−$223K	395,775
2025-12-31	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,567 sh	$30.05	−$197K	404,075
2025-12-31	RAPPRapport Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	−18K sh	—	—	410,642
2025-12-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−7,704 sh	$29.95	−$231K	393,438
2025-12-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−796 sh	$30.68	−$24.4K	392,642
2025-11-17	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,156 sh	$24.84	−$78.4K	406,486
2025-11-17	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,344 sh	$25.39	−$136K	401,142
2025-10-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−7,418 sh	$25.73	−$191K	410,724
2025-10-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,082 sh	$26.16	−$28.3K	409,642
2025-09-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,098 sh	$23.88	−$122K	421,544
2025-09-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,402 sh	$24.66	−$83.9K	418,142
2025-08-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−200 sh	$15.79	−$3,158	426,642
2025-08-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,300 sh	$14.98	−$124K	426,842
2025-07-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,500 sh	$14.00	−$119K	435,142
2025-06-16	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,500 sh	$11.00	−$93.5K	443,642
2025-05-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,500 sh	$9.56	−$81.3K	452,142
2025-04-15	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,500 sh	$9.57	−$81.3K	460,642
2025-03-14	RAPPRapport Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−8,500 sh	$10.85	−$92.2K	469,142
2025-02-03	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+100K sh	—	—	100,000
2024-06-06	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+28.3K sh	—	—	28,302

Recent filings

Accepted (ET)
Feb 194
Bredt David0001193125-26-059883
SEC(opens sec.gov)
Feb 44
Bredt David0001193125-26-037570
SEC(opens sec.gov)
Jan 164
Bredt David0001193125-26-015350
SEC(opens sec.gov)
Jan 54
Bredt David0001193125-26-002470
SEC(opens sec.gov)
Dec 164
Bredt David0001193125-25-321142
SEC(opens sec.gov)
Nov 184
Bredt David0001193125-25-286212
SEC(opens sec.gov)
Oct 164
Bredt David0001193125-25-241475
SEC(opens sec.gov)
Sep 174
Bredt David0001193125-25-206203
SEC(opens sec.gov)
Aug 184
Bredt David0000950170-25-109838
SEC(opens sec.gov)

Companies

Rapport Therapeutics, Inc.Chief Scientific OfficerRAPP

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110